The cost-effectiveness of cholesterol-lowering therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands

(De kosten-effectiviteit van verlaging van het serumcholesterol middels simvastatine in de preventie van coronaire hartziekten)


Doctoral Thesis
Related Files
asset icon
(920624_Martens, Leonardus Lambertus.pdf, 4.0MB)
asset icon
(stellingen Martens.pdf, 0.0MB)

The research presented in this dissertation was conducted to answer the question: how does the cost-effectiveness of therapy with simvastatin compare with that of current cholesterol-lowering therapy and that of other generally accepted medical practices in the Netherlands?


Supervisor (promotor):

Prof. Dr. Rutten, F.F.H.

The author wishes to thank:

The research described in this dissertation was supported by a grant in aid from Merck & Co., Inc., Rahway, New Jersey, U.S.A.


Keywords


Automatically Extracted Terms
  • cholesterol
  • disease
  • heart disease
  • heart
  • therapy
  • level
  • study
  • percent
  • serum cholesterol levels
  • serum
  • patient
  • mortality
  • model
  • effect
  • trial
  • reduction
  • serum cholesterol
  • cost-effectiveness
  • framingham study
  • result